Center4research.org

EPA released its 2024 report on artificial turf, which says it contains dangerous chemicals but that the exposures are "generally safe.' NCHR's Dr. Diana Zuckerman asks what does that mean? If it is generally safe that means it isn't safe for everyone, but EPA doesn't explain how many will be harmed and doesn't explain what is known and not known. It's not credible.

April 16th, 2024: NCHR supports CMS’ proposed rule and policies to increase oversight of Medicare accrediting organizations by addressing conflicts of interest; establishing standards, processes, and definitions for state surveys and unannounced surveys; and revising the validation survey program. We provide four key recommendations to bolster CMS' proposal.

April 15, 2024 By Robert Langreth, Fiona Rutherford and Tanaz Meghjani One ALS drug made $400 million in sales for its maker. It doesn’t work. A cancer treatment brought in $500 million. That one turned out to have no effect on survival. A blood cancer medication made nearly $850 million before being withdrawn for two […]

April 10, 2024 Today I will talk about Chemicals and Heavy Metals in Artificial Turf, Playgrounds, and Neighborhood Lawns: Policies vs. Scientific  Evidence. I’m Dr. Diana Zuckerman and I’m president of the National Center for Health Research. Our nonprofit research center and think tank is staffed by scientists, medical professionals, and public health experts. We […]

Bloomberg news describes numerous cancer drugs and other treatments that FDA approved but were found to not work after companies made billions of dollars. Diana Zuckerman and Gregg Gonsalves explain that FDA approval used to take too long but the pendulum has swung too far so that expensive drugs that don't work and may be unsafe are costing patients and our healthcare system more than it can afford.

April 12, 2024: This bill takes important steps to adequately inform consumers about the known risks of foods marketed to children and often consumed by all family members

NBC News and Kaiser Health News, April 6, 2024: NBC News reported the Kaiser Health News investigation showing that 10 doctors who advised FDA about Abbott's heart device TriClip had financial ties to the company that weren't disclosed. Their votes almost unanimously supported approval. We explain that FDA conflict of interest rules are too loose.

Washington Post, April 5, 2024: NCHR president is one of 31 scientists urging FDA to rescind approval of AvertD DNA test that purports to predict risk of opioid addiction and urging CMS to refuse to pay for the test because it does not work and can do more harm than good.

NCHR advocates for mandatory labeling of alcohol beverages that includes portion size information about alcohol content, calories, allergens, and other ingredients. We explain why voluntary standards are inadequate and that consumers need and deserve the information that would enable them to make safe and healthy decisions.

March 18, 2024: NCHR was one of 6 Consumer Safety groups submitting joint comments to the Consumer Product Safety Commission (CPSC) for its Proposed Rule for Safety Standards for Infant Support Cushions